Open Label Feasibility Pilot Study to Assess the Efficacy and Safety of the Use of Lazanda for Anxiolysis During Radiofrequency Nerve Ablation of Lumbar Facet Joints
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Fentanyl (Primary)
- Indications Anaesthesia; Pain
- Focus Adverse reactions
- 16 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 10 Dec 2015 Planned end date changed from 1 Dec 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
- 10 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.